CANCER IS OUR CAUSE
U.S. FDA sets PDUFA date for December 2026
Read the announcement about our investigational therapy for patients with metastatic colorectal cancer.
See Press Release
Building next-generation oncology franchises
Listen to our 2025 Research & Development Day to learn about our latest progress and strategies.
View Webcast
Patients are at the center of everything we do
Dusty’s journey with neuroendocrine tumors highlights the power of advocacy and community.
Watch Dusty's Story
An exceptional employee experience
Experience more purposeful work and fulfilling opportunities.
See Open Jobs
Accelerating our impact in oncology
Develop next-generation cancer medicines with us.
Let’s Collaborate
Supporting our community
We are champions for causes we believe in.
See Our Impact
Inspired by science
We are innovating at the forefront of cancer care. Our comprehensive approach is powered by a broad array of diverse biotherapeutics and small molecule programs for the treatment of cancer exploring multiple modalities and mechanisms of action.
Leveraging deep expertise in chemistry and biology, as well as strategic partnerships, we are advancing various biotherapeutics that have the potential to become anti-cancer therapies, such as bispecific antibodies, antibody-drug conjugates and other innovative treatments.
Our discovery teams are advancing multiple small molecule programs internally and through our industry collaborations.
Our R&D programs include next-generation approaches to established targets, as well as opportunities to be first-in-class by applying a range of modalities and mechanisms of action across biologics and small molecules.
